ログイン
言語:

WEKO3

  • トップ
  • ランキング
To
lat lon distance
To

Field does not validate



インデックスリンク

インデックスツリー

メールアドレスを入力してください。

WEKO

One fine body…

WEKO

One fine body…

アイテム

  1. 学会発表・講演等
  2. 口頭発表

Overview of the Carbon Ion Therapy with HIMAC in Chiba

https://repo.qst.go.jp/records/61300
https://repo.qst.go.jp/records/61300
88fd5e7b-2a0d-463a-91bf-a85a428d9a1f
Item type 会議発表用資料 / Presentation(1)
公開日 2006-02-28
タイトル
タイトル Overview of the Carbon Ion Therapy with HIMAC in Chiba
言語
言語 eng
資源タイプ
資源タイプ識別子 http://purl.org/coar/resource_type/c_c94f
資源タイプ conference object
アクセス権
アクセス権 metadata only access
アクセス権URI http://purl.org/coar/access_right/c_14cb
著者 Tsujii, Hirohiko

× Tsujii, Hirohiko

WEKO 606801

Tsujii, Hirohiko

Search repository
辻井 博彦

× 辻井 博彦

WEKO 606802

en 辻井 博彦

Search repository
抄録
内容記述タイプ Abstract
内容記述 In 1994, a clinical study on carbon-ion therapy was begun at NIRS using HIMAC (Heavy-Ion Medical Accelerator in Chiba), which was then the world痴 only heavy ion accelerator complex dedicated to medical use in a hospital environment. Among several types of ion species, carbon ions were chosen for cancer therapy because they had the most optimal properties in terms of biologically effective dose-localization in the body. The purpose of the clinical study was to investigate the efficacy of carbon ions against a variety of tumors as well as to develop effective techniques for delivering the efficient dose to the tumor. The RBE of carbon ions was estimated to be 2.0〜3.0 along the SOBP for acute skin reactions. As of July 2005, a total of 2.371 patients were entered in Phase I/II or Phase II trials and were analyzed for toxicity and tumor response. The results have shown that carbon ion therapy has the potential ability to provide a sufficient dose to the tumor with acceptable morbidity in the surrounding normal tissues. Tumors that appear to respond favorably to carbon ions include locally advanced tumors and those with histologically non-squamous cell type of tumors such as adenocarcinoma, adenoid cystic carcinoma, malignant melanoma, hepatoma, and bone and soft tissue sarcoma. By using biological and physical properties of high-LET radiations, the efficacy of treatment regimen with small fractions in short treatment times has been confirmed for almost all type of tumors in carbon ion therapy.
会議概要(会議名, 開催地, 会期, 主催者等)
内容記述タイプ Other
内容記述 NIRS-MedAustron Joint Symposium on Carbon Ion Therapy in Cancer
発表年月日
日付 2006-02-26
日付タイプ Issued
戻る
0
views
See details
Views

Versions

Ver.1 2023-05-15 21:43:59.873712
Show All versions

Share

Mendeley Twitter Facebook Print Addthis

Cite as

エクスポート

OAI-PMH
  • OAI-PMH JPCOAR 2.0
  • OAI-PMH JPCOAR 1.0
  • OAI-PMH DublinCore
  • OAI-PMH DDI
Other Formats
  • JSON
  • BIBTEX

Confirm


Powered by WEKO3


Powered by WEKO3